Liang Y - Search Results

1

p53 in Proximal Tubules Mediates Chronic Kidney Problems after Cisplatin Treatment.

Fu S, Hu X, Ma Z, Wei Q, Xiang X, Li S, Wen L, Liang Y, Dong Z. Fu S, et al. Among authors: liang y. Cells. 2022 Feb 17;11(4):712. doi: 10.3390/cells11040712. Cells. 2022. PMID: 35203361 Free PMC article.

2

Vitamin D protects glomerular mesangial cells from high glucose-induced injury by repressing JAK/STAT signaling.

Yang Y, Lei Y, Liang Y, Fu S, Yang C, Liu K, Chen Y. Yang Y, et al. Among authors: liang y. Int Urol Nephrol. 2021 Jun;53(6):1247-1254. doi: 10.1007/s11255-020-02728-z. Epub 2021 May 3. Int Urol Nephrol. 2021. PMID: 33942213 Free PMC article.

3

Exosomes in Diabetic Kidney Disease.

Wen J, Zeng M, Yang Y, Liang Y, Fu P, Dong Z. Wen J, et al. Among authors: liang y. Kidney Dis (Basel). 2023 Feb 14;9(3):131-142. doi: 10.1159/000529709. eCollection 2023 May. Kidney Dis (Basel). 2023. PMID: 37497202 Free PMC article. Review.

4

The risk factors for arteriovenous fistula dysfunction in maintenance hemodialysis patients: A cross-sectional study.

Zhang F, Yu J, Li G, Fu S, Xiao H, Yang Y, Liang Y, Chen Y, Luo X. Zhang F, et al. Among authors: liang y. Hemodial Int. 2024 Apr;28(2):170-177. doi: 10.1111/hdi.13145. Epub 2024 Mar 6. Hemodial Int. 2024. PMID: 38448796

5

Uric acid regulates NLRP3/IL-1β signaling pathway and further induces vascular endothelial cells injury in early CKD through ROS activation and K⁺ efflux.

Yin W, Zhou QL, OuYang SX, Chen Y, Gong YT, Liang YM. Yin W, et al. Among authors: liang ym. BMC Nephrol. 2019 Aug 14;20(1):319. doi: 10.1186/s12882-019-1506-8. BMC Nephrol. 2019. PMID: 31412804 Free PMC article.

6

NR4A1 silencing protects against renal ischemia-reperfusion injury through activation of the β-catenin signaling pathway in old mice.

Shi W, Dong J, Liang Y, Liu K, Peng Y. Shi W, et al. Among authors: liang y. Exp Mol Pathol. 2019 Dec;111:104303. doi: 10.1016/j.yexmp.2019.104303. Epub 2019 Aug 26. Exp Mol Pathol. 2019. PMID: 31465766

7

Potential risk of the kidney vulnerable to novel coronavirus 2019 infection.

Zhang F, Liang Y. Zhang F, et al. Among authors: liang y. Am J Physiol Renal Physiol. 2020 May 1;318(5):F1136-F1137. doi: 10.1152/ajprenal.00085.2020. Epub 2020 Mar 30. Am J Physiol Renal Physiol. 2020. PMID: 32223555 Free PMC article. No abstract available.

8

CD4+CD25+ cells in multiple myeloma related renal impairment.

Huang H, Luo Y, Liang Y, Long XD, Peng Y, Liu Z, Wen X, Jia M, Tian R, Bai C, Li C, Dong X. Huang H, et al. Among authors: liang y. Sci Rep. 2015 Nov 13;5:16565. doi: 10.1038/srep16565. Sci Rep. 2015. PMID: 26564056 Free PMC article.

9

ATP-citrate lyase is an epigenetic regulator to promote obesity-related kidney injury.

Chen Y, Deb DK, Fu X, Yi B, Liang Y, Du J, He L, Li YC. Chen Y, et al. Among authors: liang y. FASEB J. 2019 Aug;33(8):9602-9615. doi: 10.1096/fj.201900213R. Epub 2019 May 31. FASEB J. 2019. PMID: 31150280 Free PMC article.

Collectively, these data suggest that ACL is an epigenetic regulator that promotes renal ELA and fibrogenesis leading to renal injury in obesity.-Chen, Y., Deb, D. K., Fu, X., Yi, B., Liang, Y., Du, J., He, L., Li, Y. ...

Collectively, these data suggest that ACL is an epigenetic regulator that promotes renal ELA and fibrogenesis leading to renal injury in obe …

10

The therapeutic effect of dendritic cells expressing indoleamine 2,3-dioxygenase (IDO) on an IgA nephropathy mouse model.

Liu K, Yang Y, Chen Y, Li S, Gong Y, Liang Y. Liu K, et al. Among authors: liang y. Int Urol Nephrol. 2020 Feb;52(2):399-407. doi: 10.1007/s11255-019-02365-1. Epub 2020 Jan 1. Int Urol Nephrol. 2020. PMID: 31894556

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21,638 results

Search Page